Contribute to RSV Research:
Navigating the challenges of RSV (Respiratory Syncytial Virus) in adults can be demanding due to its potential to cause severe respiratory illness. While typically associated with infants, RSV can also affect adults, particularly those with weakened immune systems or underlying health conditions. Our current vaccine studies offer an opportunity to contribute to preventative measures against RSV.
⦁ Open to adults ages 18 and over
⦁ Participation doesn’t require health insurance
⦁ Compensation may be provided for time and travel.
Sign up today to see if you qualify for our RSV clinical trial!
